Sales of $10.6 billion driven by strong underlying base business performance Reported sales growth of 4.9 percent; organic sales growth for underlying base business of 8.2 percent 1 , led by double-digit growth in Medical Devices Continues to strengthen portfolio with steady cadence of new product approvals, reimbursement coverage, and clinical data ABBOTT PARK , Ill. , Oct. 16, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today... Read More